We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NN:EURONEXT AMSTERDAMNN Group N.V. Analysis

Data as of 2026-05-24 - not real-time

$21.74

Latest Price

8/10Risk

Risk Level: High

Executive Summary

NextNav is trading in a clear bullish technical environment, with short‑term moving averages positioned above longer‑term averages and a MACD that remains in bullish territory. The RSI sits in the upper‑mid range, indicating momentum without being overbought, while volume has been on an upward trend, supporting the price advance. The stock is holding above a well‑defined support level and faces resistance near recent highs, offering a modest upside corridor. Recent participation in industry conferences underscores the company’s leadership in 3D positioning and timing solutions, which could catalyze further demand.
However, the fundamentals are markedly weak, with negative margins, substantial operating losses, and a price‑to‑sales multiple that is exceptionally high. The balance sheet shows more debt than cash, and cash flow generation is negative, raising concerns about sustainability. Combined with elevated volatility and a beta that exceeds the market, the risk profile is pronounced, suggesting that investors should weigh the technical upside against the underlying financial strain.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD and supportive volume trend
  • Price holding above key support level
  • High short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Analyst consensus of strong buy and positive upside potential
  • Strategic positioning in emerging 3D PNT market
  • Potential catalyst from upcoming industry conferences

Long Term

> 3 years
Cautious
Model confidence: 5/10

Key Factors

  • Persistent negative earnings and cash flow
  • Elevated debt relative to cash reserves
  • Sustained high volatility and beta indicating market sensitivity

Key Metrics & Analysis

Financial Health

Revenue Growth-35.30%
P/E Ratio-29.8
ROA-17.30%
P/B Ratio-32.9
Op. Cash Flow$-48607000
Free Cash Flow$-19809124
Industry P/E39.5

Technical Analysis

TrendBullish
RSI58.2
Support$15.33
Resistance$24.10
MA 20$20.05
MA 50$18.64
MA 200$16.03
MACDBullish
VolumeIncreasing
Fear & Greed Index91.61

Valuation

Target Price$27.00
Upside/Downside24.20%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta1.49
Volatility116.09%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.